Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
02/28/1996 | EP0362367B1 Osteogenic devices |
02/28/1996 | CN1117742A Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
02/28/1996 | CN1117525A Arnebia euchroma (Royle) Johnst. cell cultivation and prodn. process by solid two step method |
02/27/1996 | US5495071 Genetic engineering |
02/27/1996 | US5494899 Immunomodulation of bone marrow cells in culture using hormones during pregnancy, such as estrogen; autoimmune disorders, osteoporosis |
02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
02/27/1996 | US5494792 Kainate-binding, human CNS receptors of the EAA2 family |
02/27/1996 | US5494791 Monoclonal antibodies against glycated low density lipoprotein |
02/27/1996 | CA2114311C Monoclonal wb b-cell line |
02/27/1996 | CA2018228C Cell culture systems and media |
02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
02/22/1996 | WO1996005317A1 Ga4 dna, protein and methods of use |
02/22/1996 | WO1996005314A2 Protein toxins active against lepidopteran pests |
02/22/1996 | WO1996005313A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
02/22/1996 | WO1996005309A2 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
02/22/1996 | WO1996005308A1 Method for diagnosing a predisposition for breast and ovarian cancer |
02/22/1996 | WO1996005307A2 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
02/22/1996 | WO1996005306A2 IN VIVO MUTATIONS AND POLYMORPHISMS IN THE 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
02/22/1996 | WO1996005291A1 Recombinant herpesvirus of turkeys and uses thereof |
02/22/1996 | WO1996005290A1 Bone precursor cells: compositions and methods |
02/22/1996 | WO1996005289A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
02/22/1996 | WO1996005288A2 T cell activation |
02/22/1996 | WO1996005286A2 Cell death accelerator and cell death inhibitor |
02/22/1996 | WO1996005230A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
02/22/1996 | WO1996005225A1 Adrenergic receptor |
02/22/1996 | WO1996005221A1 Calcitonin receptor |
02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
02/22/1996 | WO1996004789A1 A method of selectively destroying neoplastic cells |
02/22/1996 | WO1995025171A3 Dna sequences for matrix metalloproteases, their production and use |
02/22/1996 | DE19503359C1 Plants with increased tolerance towards stress |
02/22/1996 | CA2200197A1 Bone precursor cells: compositions and methods |
02/22/1996 | CA2197801A1 T cell activation |
02/22/1996 | CA2197753A1 Ga4 dna, protein and methods of use |
02/22/1996 | CA2197712A1 Vaccines containing borrelia burgdorferi ospg |
02/22/1996 | CA2196756A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
02/22/1996 | CA2196080A1 Protein toxins active against lepidopteran pests |
02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
02/20/1996 | US5492820 Plasmids for the production of transgenic plants that are modified in habit and yield |
02/20/1996 | US5492314 Preloaded digressive rate mount |
02/15/1996 | WO1996004395A1 Recombinant virus vectors |
02/15/1996 | WO1996004393A2 Control of plant gene expression |
02/15/1996 | WO1996004391A1 Method for selecting high-expressing host cells |
02/15/1996 | WO1996004388A1 Novel compounds |
02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
02/15/1996 | WO1996004372A1 Ikaros transgenic cells and animals |
02/15/1996 | WO1996004368A1 Propagation and inducible differentiation of human fetal central nervous system progenitor cells |
02/15/1996 | WO1996004367A1 Cell culturing method |
02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
02/15/1996 | WO1996004310A1 Contraceptive vaccine |
02/15/1996 | WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
02/15/1996 | WO1996003937A1 Method for modifying the internal surface of synthetic prosthesis used in vascular surgery |
02/15/1996 | WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods |
02/15/1996 | WO1996002645A3 Htk ligand |
02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
02/15/1996 | WO1995026982A3 Malaria peptides |
02/15/1996 | DE4427217A1 Zellkulturverfahren Cell culture method |
02/15/1996 | CA2196285A1 Contraceptive vaccine |
02/15/1996 | CA2196200A1 Novel compounds |
02/15/1996 | CA2196190A1 Ikaros transgenic cells and animals |
02/15/1996 | CA2196168A1 Recombinant virus vectors |
02/15/1996 | CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
02/15/1996 | CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
02/14/1996 | EP0696639A1 Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells |
02/14/1996 | EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids |
02/14/1996 | EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
02/14/1996 | EP0696317A1 HUMAN $i(SYK) |
02/14/1996 | EP0696205A1 Use of neuro-derived fetal cell lines for transplantation therapy |
02/14/1996 | EP0696163A1 Coated meristermatic tissue |
02/14/1996 | EP0389538B1 yETHOD OF PURIFYING RECOMBINANT t-PA FROM CORRESPONDING HOST CELL PROTEINS |
02/14/1996 | CN1116655A Process for gene tranfer into plant cells |
02/14/1996 | CN1116654A Preserved, non-infectious control cells for use in the identification of a disease through blood testing |
02/14/1996 | CN1116549A High affinity tumor killer cell (T-AK cell) preparation |
02/14/1996 | CA2155920A1 Use of interferon for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells |
02/13/1996 | US5491288 Chimeric gene comprising the arabidopsis histone H4 promoter for the transformation of plants |
02/13/1996 | US5491284 Nude mouse model for neoplastic disease |
02/13/1996 | US5491090 Embryogenic coniferous liquid suspension cultures |
02/13/1996 | US5491088 Genetic engineering |
02/13/1996 | US5491080 Genetic engineering of integrating a dna sequence encoding a protein specifically breaking a double-strain rna into a plant chromosome |
02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
02/13/1996 | US5491066 Specifically reacts with active human ceruloplasmin; diagnosis of wilson's disease |
02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |
02/08/1996 | WO1996003649A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
02/08/1996 | WO1996003520A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
02/08/1996 | WO1996003513A2 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
02/08/1996 | WO1996003504A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
02/08/1996 | WO1996003496A1 Culture medium promoting endocrine cell growth |
02/08/1996 | WO1996003495A1 Bradykinin b2 receptor modified transgenic non-human animals |